On 1st July, Australia became the first country to allow psychiatrists to prescribe MDMA, also known as ecstasy, for PTSD. Psilocybin, the psychoactive ingredient in hallucinogenic (or ‘magic ...

Chemical professionals should treat others with respect and will not engage in discrimination, harassment, bullying, dishonesty, fraud, misrepresentation, coercive manipulation, censorship, or other ...

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...

Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Tryptamine Therapeutics has successfully completed its Phase 1b trial of TRP-8803, an IV-infused psilocin ...

Small molecules are low molecular weight molecules that include lipids, monosaccharides, second messengers, other natural products and metabolites, as well as drugs and other xenobiotics.

Tryptamine Therapeutics (AU:TYP) has released an update. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with ...

Tryptamine Therapeutics has successfully completed obese-subject dosing in the phase 1b study of its novel IV-infused psilocin formulation, TRP-8803. Three participants were safely administered ...

In the US alone, one in five adults experiences a form of mental illness each year. New medicines are urgently needed, as current therapies fail to work in up to a third of patients. Dr Cheryl ...

ACS Publications’ commitment to publishing high-quality content continues to attract impactful research that addresses the world’s most important challenges.

Often known as the central science, it is a creative discipline chiefly concerned with atomic and molecular structure and its change, for instance through chemical reactions. A one-dimensional ...

Tryptamine Therapeutics has successfully completed obese-subject dosing in the phase 1b study of its novel IV-infused psilocin formulation, TRP-8803. Don't miss out on the headlines from Stockhead ...